Cow's first milk could be a lifeline for severe Alcohol-Related hepatitis
NCT ID NCT02473341
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This phase 3 trial investigates whether bovine colostrum—the nutrient-rich first milk from cows—can improve survival in people with severe alcohol-associated hepatitis. The condition involves liver inflammation, a leaky gut, and a high risk of infection. Participants receive either colostrum powder or a placebo for four weeks, alongside standard care. The study measures survival at 90 days and changes in liver function and inflammation markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bovine colostrum (freeze-dried powder, 20 grams three times a day for 4 weeks)
- What this could lead to
- If effective, bovine colostrum could offer a new, affordable treatment to improve survival in severe alcohol-associated hepatitis, a condition with limited options.
- What could go wrong
- This is a single trial with 174 participants, and previous promising treatments for this condition have failed in larger studies. The benefit may be modest or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLIC HEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences
New Delhi, India
-
Department of Gastroenterology, Dayanand Medical College and Hospital
Ludhiana, Punjab, 141001, India
-
Department of Hepatology, Global Hospital
Hyderabad, India
-
Post Graduate Medical Institute of Medical Education and Research
Chandigarh, India
-
Sawai Man Singh Medical College
Jaipur, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Can a text-and-therapy program keep liver transplant patients sober?
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- Liver failure treatment MARS: does it help avoid transplants?
- Liver bacteria may hold key to new alcoholic hepatitis treatments
- Zambia hepatitis b survey reveals who needs treatment